RxDoctor Payments Data

Keith Hull

Neurology · Raleigh, NCNPI 1508896069

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,599 of the $36,336 with a category attached, or 84.2%. 29 manufacturers reported payments, led by Adamas Pharmaceuticals, Inc. at 49.7% of the total. Reporting peaked in 2019 at $19,095 and has fallen 99.8% since, to $43 in 2025.

$36,336in general payments, 2019–2025

Across 118 payments — averaging $307.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adamas Pharmaceuticals, Inc.$18K
  • Acorda Therapeutics, Inc$17K
  • Sanofi$261
  • EDW Pharma, Inc.$138
  • Novartis$126
  • Amgen$98
  • plus $620 from 23 others
$56,250in research payments, 2019–2025

Across 8 payments — averaging $7031.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acadia Pharmaceuticals Inc$56K

What the payments were for

  • Consulting fees$1,3654%
  • Speaking & faculty fees$30,59984%
  • Travel & lodging$2,3697%
  • Food & beverage$2,0036%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,336 in reported general payments places this provider in the 85th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina →

Other neurology in Raleigh

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →